TMEM101

gene
On this page

Also known as MGC4251FLJ23987

Summary

TMEM101 (transmembrane protein 101, HGNC:28653) is a protein-coding gene on chromosome 17q21.31, encoding Transmembrane protein 101 (Q96IK0). May activate NF-kappa-B signaling pathways.

Involved in positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in membrane.

Source: NCBI Gene 84336 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 18 total
  • MANE Select transcript: NM_032376

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28653
Approved symbolTMEM101
Nametransmembrane protein 101
Location17q21.31
Locus typegene with protein product
StatusApproved
AliasesMGC4251, FLJ23987
Ensembl geneENSG00000091947
Ensembl biotypeprotein_coding
Entrez84336

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 8 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000206380, ENST00000585950, ENST00000586174, ENST00000587529, ENST00000589334, ENST00000590905, ENST00000591162, ENST00000592127, ENST00000860792

RefSeq mRNA: 3 — MANE Select: NM_032376 NM_001304813, NM_001304814, NM_032376

CCDS: CCDS11474

Canonical transcript exons

ENST00000206380 — 4 exons

ExonStartEnd
ENSE000005885234401481644014963
ENSE000038922394401118844012236
ENSE000038955014401300944013155
ENSE000038955624401435744014537

Expression profiles

Bgee: expression breadth ubiquitous, 235 present calls, max score 95.09.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.7027 / max 94.9461, expressed in 1794 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
16629116.67041790
1662930.01636
1662920.01014
1662940.00593

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
metanephros cortexUBERON:001053395.09gold quality
endometriumUBERON:000129594.41gold quality
seminal vesicleUBERON:000099893.21gold quality
body of pancreasUBERON:000115091.54gold quality
mucosa of transverse colonUBERON:000499191.28gold quality
tendon of biceps brachiiUBERON:000818891.12gold quality
hindlimb stylopod muscleUBERON:000425290.37gold quality
body of stomachUBERON:000116190.05gold quality
stromal cell of endometriumCL:000225590.02gold quality
right uterine tubeUBERON:000130289.68gold quality
buccal mucosa cellCL:000233689.61gold quality
apex of heartUBERON:000209889.59gold quality
gastrocnemiusUBERON:000138889.02gold quality
left testisUBERON:000453388.97gold quality
skin of abdomenUBERON:000141688.94gold quality
lower esophagus mucosaUBERON:003583488.73gold quality
right testisUBERON:000453488.64gold quality
muscle of legUBERON:000138388.61gold quality
endocervixUBERON:000045888.52gold quality
granulocyteCL:000009488.42gold quality
right lobe of thyroid glandUBERON:000111988.37gold quality
minor salivary glandUBERON:000183088.33gold quality
body of uterusUBERON:000985388.29gold quality
pancreasUBERON:000126488.25gold quality
skin of legUBERON:000151188.25gold quality
vaginaUBERON:000099688.24gold quality
monocyteCL:000057688.20gold quality
esophagus mucosaUBERON:000246988.05gold quality
leukocyteCL:000073887.95gold quality
testisUBERON:000047387.86gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-MTAB-10287yes50.05
E-CURD-119yes44.50
E-ANND-3yes12.02
E-MTAB-6678yes9.92
E-MTAB-7606no1255.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

46 targeting TMEM101, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-797899.8666.90856
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-442299.7272.072908
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-452799.6667.43714
HSA-MIR-6503-5P99.6266.96597
HSA-MIR-4761-5P99.5166.69804
HSA-MIR-6505-3P99.3467.391071
HSA-MIR-532-3P99.3465.761195
HSA-MIR-4520-2-3P99.1469.281009
HSA-MIR-316499.0268.391071
HSA-MIR-6820-3P99.0268.501035
HSA-MIR-3619-5P99.0068.872308
HSA-MIR-1207-3P98.9966.221532
HSA-MIR-548Q98.7165.35563

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotmem101ENSDARG00000114508
mus_musculusTmem101ENSMUSG00000020921
rattus_norvegicusTmem101ENSRNOG00000054581

Protein

Protein identifiers

Transmembrane protein 101Q96IK0 (reviewed: Q96IK0)

Alternative names: Putative NF-kappa-B-activating protein 130

All UniProt accessions (5): Q96IK0, K7EM07, K7EM72, K7EPU9, K7ERS4

UniProt curated annotations — full annotation on UniProt →

Function. May activate NF-kappa-B signaling pathways.

Subcellular location. Membrane.

RefSeq proteins (3): NP_001291742, NP_001291743, NP_115752* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029371TMEM101Family

Pfam: PF15111

UniProt features (9 total): transmembrane region 8, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96IK0-F189.340.60

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 121 (showing top): GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, LUND_SILENCED_BY_METHYLATION, SMID_BREAST_CANCER_LUMINAL_B_UP, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, HAN_SATB1_TARGETS_DN, GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, SCGGAAGY_ELK1_02, ER_Q6_01, HATADA_METHYLATED_IN_LUNG_CANCER_UP, ZWANG_EGF_INTERVAL_DN, ALKBH3_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES, FOXN3_TARGET_GENES

GO Biological Process (1): positive regulation of canonical NF-kappaB signal transduction (GO:0043123)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
canonical NF-kappaB signal transduction1
regulation of canonical NF-kappaB signal transduction1
positive regulation of intracellular signal transduction1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

554 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM101TMEM223A0PJW6562
TMEM101TMEM208Q9BTX3510
TMEM101RPP40O75818506
TMEM101TMEM59LQ9UK28486
TMEM101FAM181BA6NEQ2477
TMEM101TMEM115Q12893472
TMEM101CDKL2Q92772445
TMEM101LAGE3Q14657445
TMEM101LCA5Q86VQ0432
TMEM101GATAD1Q8WUU5429
TMEM101CDC23Q9UJX2414
TMEM101KRCC1Q9NPI7412
TMEM101FHAD1B1AJZ9411
TMEM101NTRK1P04629402
TMEM101UBIAD1Q9Y5Z9389

IntAct

65 interactions, top by confidence:

ABTypeScore
STRIT1TMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM243TMEM101psi-mi:“MI:0915”(physical association)0.560
STX10TMEM101psi-mi:“MI:0915”(physical association)0.560
NINJ2TMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM101BNIP3psi-mi:“MI:0915”(physical association)0.560
VAMP1TMEM101psi-mi:“MI:0915”(physical association)0.560
ARLNTMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM65TMEM101psi-mi:“MI:0915”(physical association)0.560
BNIP3TMEM101psi-mi:“MI:0915”(physical association)0.560
VAMP2TMEM101psi-mi:“MI:0915”(physical association)0.560
PDZK1IP1TMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM101TMEM243psi-mi:“MI:0915”(physical association)0.560
VAPBTMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM101NINJ2psi-mi:“MI:0915”(physical association)0.560
TMEM101PKMYT1psi-mi:“MI:0915”(physical association)0.560
NDUFA3TMEM101psi-mi:“MI:0915”(physical association)0.560
TMEM101psi-mi:“MI:0915”(physical association)0.560

BioGRID (33): TMEM101 (Affinity Capture-RNA), STX10 (Two-hybrid), VAPB (Two-hybrid), PKMYT1 (Two-hybrid), TMEM243 (Two-hybrid), VAMP1 (Two-hybrid), PDZK1IP1 (Two-hybrid), C4orf3 (Two-hybrid), TMEM65 (Two-hybrid), NDUFA3 (Two-hybrid), NINJ2 (Two-hybrid), BNIP3 (Two-hybrid), TMIE (Two-hybrid), GIMAP1 (Two-hybrid), SYNJ2BP (Two-hybrid)

ESM2 similar proteins: A0A0N0DCA4, A0A194XK05, A0A7L9EZ67, A0A8F4NUZ8, A0A8F4S726, C6Y4A4, D2I2F3, G5EEQ9, O94440, P0DXW0, P32564, P34296, P53748, Q0VD15, Q10255, Q10436, Q12155, Q29RQ9, Q3B8H0, Q53FV1, Q55E32, Q5E972, Q5R570, Q5R8X5, Q5RFN8, Q5VVB8, Q5XH57, Q5XJR6, Q5ZIU0, Q6NZZ4, Q6QI25, Q6UX40, Q74ZU2, Q86H65, Q8JFB7, Q8N138, Q8STK5, Q8SW90, Q91VP7, Q921I0

Diamond homologs: Q2KIB3, Q5RFN8, Q91VP7, Q96IK0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

18 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance17
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

942 predictions. Top by Δscore:

VariantEffectΔscore
17:44013151:CGGAC:Cacceptor_gain1.0000
17:44013162:C:CTacceptor_gain1.0000
17:44013163:G:Tacceptor_gain1.0000
17:44014351:GCTCA:Gdonor_loss1.0000
17:44014352:CTCA:Cdonor_loss1.0000
17:44014353:TCACC:Tdonor_loss1.0000
17:44014354:CACCT:Cdonor_loss1.0000
17:44014355:A:ACdonor_gain1.0000
17:44014356:C:CCdonor_gain1.0000
17:44014356:CCTT:Cdonor_gain1.0000
17:44014546:C:CTacceptor_gain1.0000
17:44014547:G:Tacceptor_gain1.0000
17:44014551:G:Cacceptor_gain1.0000
17:44014551:G:GCacceptor_gain1.0000
17:44012232:TAGGC:Tacceptor_gain0.9900
17:44012234:GGCC:Gacceptor_loss0.9900
17:44012235:GCC:Gacceptor_loss0.9900
17:44012237:C:CCacceptor_gain0.9900
17:44013004:CAT:Cdonor_loss0.9900
17:44013007:A:ACdonor_gain0.9900
17:44013007:ACC:Adonor_loss0.9900
17:44013008:C:CCdonor_gain0.9900
17:44013008:C:CTdonor_gain0.9900
17:44013008:CCA:Cdonor_gain0.9900
17:44013008:CCACA:Cdonor_gain0.9900
17:44013155:CCTAG:Cacceptor_loss0.9900
17:44013156:C:CCacceptor_gain0.9900
17:44014355:AC:Adonor_gain0.9900
17:44014356:CC:Cdonor_gain0.9900
17:44014356:CCT:Cdonor_gain0.9900

AlphaMissense

1640 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:44014474:A:CS67R0.999
17:44014474:A:TS67R0.999
17:44014476:T:GS67R0.999
17:44012002:A:GW234R0.998
17:44012002:A:TW234R0.998
17:44013029:C:GG149R0.995
17:44013099:G:CS125R0.995
17:44013099:G:TS125R0.995
17:44013101:T:GS125R0.995
17:44014868:A:GW29R0.995
17:44014868:A:TW29R0.995
17:44012029:A:GW225R0.993
17:44012029:A:TW225R0.993
17:44013043:C:TG144D0.993
17:44013119:C:GG119R0.993
17:44013121:C:TG118D0.993
17:44013122:C:GG118R0.993
17:44013130:G:TA115D0.993
17:44011959:C:TG248E0.992
17:44014365:A:GW104R0.992
17:44014365:A:TW104R0.992
17:44012000:C:AW234C0.991
17:44012000:C:GW234C0.991
17:44012027:C:AW225C0.991
17:44012027:C:GW225C0.991
17:44013044:C:GG144R0.991
17:44014441:G:CF78L0.991
17:44014441:G:TF78L0.991
17:44014443:A:GF78L0.991
17:44014478:G:TA66D0.991

dbSNP variants (sampled 300 via entrez): RS1000233251 (17:44013649 ACT>A), RS1000506535 (17:44016707 A>C), RS1000612799 (17:44022939 C>T), RS1000959208 (17:44018620 G>A), RS1001011597 (17:44018136 A>C), RS1001213873 (17:44016339 A>G), RS1001629646 (17:44021201 AG>A), RS1001922267 (17:44023874 G>A), RS1002288829 (17:44024083 C>A,G,T), RS1002310749 (17:44015084 G>C,T), RS1002481557 (17:44018074 G>A), RS1002569675 (17:44017664 G>A), RS1002588511 (17:44018394 G>A,C,T), RS1002954394 (17:44014304 C>G,T), RS1002985435 (17:44014633 C>A,G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression2
aristolochic acid Idecreases expression1
potassium chromate(VI)increases expression1
coumarinincreases phosphorylation1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
(+)-JQ1 compounddecreases expression1
Arsenicaffects methylation1
Estradioldecreases expression1
Hydrogen Peroxideaffects expression1
Smokedecreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.